rs1143634

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_000576.3(IL1B):​c.315C>T​(p.Phe105Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 1,613,312 control chromosomes in the GnomAD database, including 40,737 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign,Affects,association,other (no stars).

Frequency

Genomes: 𝑓 0.19 ( 3058 hom., cov: 32)
Exomes 𝑓: 0.22 ( 37679 hom. )

Consequence

IL1B
NM_000576.3 synonymous

Scores

2

Clinical Significance

Benign; Affects; association; other no assertion criteria provided B:1O:3

Conservation

PhyloP100: -0.677

Publications

1252 publications found
Variant links:
Genes affected
IL1B (HGNC:5992): (interleukin 1 beta) The protein encoded by this gene is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. Similarly, IL-1B has been implicated in human osteoarthritis pathogenesis. Patients with severe Coronavirus Disease 2019 (COVID-19) present elevated levels of pro-inflammatory cytokines such as IL-1B in bronchial alveolar lavage fluid samples. The lung damage induced by the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is to a large extent, a result of the inflammatory response promoted by cytokines such as IL-1B. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. [provided by RefSeq, Jul 2020]
IL1B Gene-Disease associations (from GenCC):
  • hereditary diffuse gastric adenocarcinoma
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-112832813-G-A is Benign according to our data. Variant chr2-112832813-G-A is described in ClinVar as Benign|Affects|association|other. ClinVar VariationId is 869137.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.677 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.231 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL1BNM_000576.3 linkc.315C>T p.Phe105Phe synonymous_variant Exon 5 of 7 ENST00000263341.7 NP_000567.1
IL1BXM_047444175.1 linkc.81C>T p.Phe27Phe synonymous_variant Exon 2 of 4 XP_047300131.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL1BENST00000263341.7 linkc.315C>T p.Phe105Phe synonymous_variant Exon 5 of 7 1 NM_000576.3 ENSP00000263341.2

Frequencies

GnomAD3 genomes
AF:
0.192
AC:
29258
AN:
152020
Hom.:
3053
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.132
Gnomad AMI
AF:
0.319
Gnomad AMR
AF:
0.172
Gnomad ASJ
AF:
0.273
Gnomad EAS
AF:
0.0219
Gnomad SAS
AF:
0.150
Gnomad FIN
AF:
0.248
Gnomad MID
AF:
0.345
Gnomad NFE
AF:
0.234
Gnomad OTH
AF:
0.208
GnomAD2 exomes
AF:
0.192
AC:
48238
AN:
251472
AF XY:
0.197
show subpopulations
Gnomad AFR exome
AF:
0.131
Gnomad AMR exome
AF:
0.113
Gnomad ASJ exome
AF:
0.281
Gnomad EAS exome
AF:
0.0195
Gnomad FIN exome
AF:
0.244
Gnomad NFE exome
AF:
0.241
Gnomad OTH exome
AF:
0.219
GnomAD4 exome
AF:
0.221
AC:
323017
AN:
1461174
Hom.:
37679
Cov.:
34
AF XY:
0.221
AC XY:
160625
AN XY:
726932
show subpopulations
African (AFR)
AF:
0.135
AC:
4505
AN:
33466
American (AMR)
AF:
0.117
AC:
5237
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.278
AC:
7272
AN:
26130
East Asian (EAS)
AF:
0.0332
AC:
1318
AN:
39700
South Asian (SAS)
AF:
0.166
AC:
14325
AN:
86246
European-Finnish (FIN)
AF:
0.251
AC:
13391
AN:
53418
Middle Eastern (MID)
AF:
0.314
AC:
1812
AN:
5768
European-Non Finnish (NFE)
AF:
0.236
AC:
262323
AN:
1111356
Other (OTH)
AF:
0.213
AC:
12834
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
12932
25865
38797
51730
64662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8736
17472
26208
34944
43680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.192
AC:
29277
AN:
152138
Hom.:
3058
Cov.:
32
AF XY:
0.191
AC XY:
14216
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.132
AC:
5483
AN:
41514
American (AMR)
AF:
0.172
AC:
2626
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.273
AC:
948
AN:
3468
East Asian (EAS)
AF:
0.0222
AC:
115
AN:
5188
South Asian (SAS)
AF:
0.150
AC:
725
AN:
4818
European-Finnish (FIN)
AF:
0.248
AC:
2623
AN:
10562
Middle Eastern (MID)
AF:
0.347
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
0.234
AC:
15927
AN:
67982
Other (OTH)
AF:
0.207
AC:
437
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1192
2384
3577
4769
5961
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.220
Hom.:
14334
Bravo
AF:
0.182
Asia WGS
AF:
0.114
AC:
397
AN:
3478
EpiCase
AF:
0.239
EpiControl
AF:
0.239

ClinVar

Significance: Benign; Affects; association; other
Submissions summary: Benign:1Other:3
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

IL1B-related disorder Benign:1
Nov 19, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Antisynthetase syndrome Other:1
Feb 10, 2020
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas
Significance:association
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Endometriosis Other:1
Oct 20, 2021
Laboratorio de Investigación del Departamento de Salud, Universidad Iberoamericana A.C.
Significance:Affects
Review Status:no assertion criteria provided
Collection Method:case-control

Mexican mestizo women with severe stage of endometriosis have higher frequencies of TNF*2-, IL1B*2- and IL1RN*2-alleles, which may explain a possible correlation with disease severity rather than predisposition or risk. -

Cholangiocarcinoma Other:1
Dec 10, 2022
Department of Surgery, Campus Charité Mitte Campus Virchow-klinikum, Charite-Universitaetsmedizin Berlin
Significance:other
Review Status:no assertion criteria provided
Collection Method:research

C/C genotype associated with significantly shorter OS after surgical resection of intrahepatic CCA C/C genotype associated with shorter overall survival

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
2.1
DANN
Benign
0.82
PhyloP100
-0.68
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1143634; hg19: chr2-113590390; COSMIC: COSV54523425; COSMIC: COSV54523425; API